Figure S4 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

Authors :: Yves Allenbach
Thomas Similowski
Michelle Rosenzwajg
Javid J. Moslehi
Juan Qin
Lorenz Lehmann
Capucine Morelot-Panzini
Claudia Llontop
Noel Zahr
Nadjib Hammoudi
Mathieu Kerneis
Estelle Gandjbakhch
Isabelle Plu
Philippe Rouvier
Samir Saheb
Nicolas Weiss
Olivier Benveniste
Nicolas Champtiaux
Perrine Guillaume-Jugnot
Aude Rigolet
David Klatzmann
Jesus Gonzalez-Bermejo
Christian Straus
Guillaume Hekimian
Marc Pineton De Chambrun
Thierry Maisonobe
Timothee Lenglet
Dimitri Psimaras
Alexandre Demoule
Martin Dres
Paul Gougis
Perrine Devos
Charlotte Fenioux
Frederic Stein
Adrien Procureur
Lee S. Nguyen
Samia Boussouar
Alban Redheuil
Stéphane Ederhy
Sarah Leonard-Louis
Baptiste Abbar
Marie Bretagne
Joe-Elie Salem
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Example of the first severe ICI-myocarditis case treated with abatacept guided by real-time immune-monitoring assessment of CD86RO (CD86 receptor occupancy) on circulating monocytes.

Tools